Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized controlled trial of the Lund concept for severe traumatic brain injury
ChiCTR1900026592Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Zhengzhou University
- Start
- Sep 2019
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of albumin (human), metoprolol, esmolol, dexmedetomidine, losartan and 3 more in traumatic brain injury (TBI) (2 arms), sponsored by The First Affiliated Hospital of Zhengzhou University. Primary endpoint: 28-day mortality rate. Planned start Sep 2019; status: not yet recruiting.
02
Drugs
albumin (human)metoprololesmololdexmedetomidinelosartan
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on ChiCTR1900026592.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900026592.